Fidelity Advisor Health Care Fund
FHCIX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 245 Summer Street Boston MA United States of America 2210
- IPO Date
- Aug 30, 1996
- CIK
- 0000315700
- Website
- fundresearch.fidelity.com
- Similar Companies
- Business
- Fidelity Advisor Health Care Fund (FHCIX) is an open-end mutual fund managed by Fidelity Investments that seeks capital appreciation by investing primarily in common stocks of companies engaged in the design, manufacture, or sale of products or services related to health care or medicine; at least 80% of assets are allocated to such securities, including domestic and foreign issuers across pharmaceuticals, biotechnology, medical devices, health care equipment, supplies, and services providers. The fund employs fundamental analysis of issuers' financial condition, industry position, market trends, and economic conditions to select investments, maintaining a diversified portfolio of approximately 127 holdings with top positions in companies such as Boston Scientific Corp, Danaher Corp, Eli Lilly and Co, Penumbra Inc, and Alnylam Pharmaceuticals Inc; sector allocation is heavily weighted toward health care at around 95-100%, with primarily U.S. stocks (about 90%) supplemented by non-U.S. equities, minimal bonds, and cash. Launched on September 3, 1996, and domiciled in the United States with Fidelity Investments headquartered in Boston, Massachusetts, the fund targets institutional and high-net-worth investors through its Class I shares, which feature a net expense ratio of 0.68%, no front-end or deferred loads, and total net assets exceeding $3.3 billion. Edward Yoon serves as the lead portfolio manager since October 10, 2008, overseeing the fund as part of Fidelity's Equity division and Global Health Care Research Team, with an average management tenure reflecting long-term stability. No major strategic changes, such as partnerships, acquisitions, funding rounds, new product launches, or reorganizations specific to FHCIX, have been reported in the last 1-2 years; the fund continues its established growth-oriented strategy within the Morningstar Health category, with ongoing portfolio adjustments reflected in recent holdings and performance data as of mid-2025.